More articles from Volume 44, Issue 1, 2015
HLORINIŠUĆA AKTIVNOST SERUMSKE MIJELOPEROKSIDAZE U AKUTNOM ISHEMIČNOM MOŽDANOM UDARU
KVANTITATIVNA ANALIZA MAKROFAGA U GINGIVITISU I PARODONTOPATIJI
Is hypertension, in children who are on chronic hemodialysis therapy, crucial for the development of cardiac hypertrophy?
LEČENJE INFERTILNIH I SUBFERTILNIH MUŠKARACA SA VARIKOKELOM MINIMALNO INVAZIVNIM HIRURŠKIM METODOM
HISTOLOŠKO-CITOLOŠKA KORELACIJA NALAZA I POUZDANOST PAPANICOLAU TESTA U OTKRIVANJU PREMALIGNIH I MALIGNIH PROMENA NA GRLIĆU MATERICE
NEZELJENA DEJSTVA NSAR NA SLUZNICI GASTRODUODENUMA ORDINIRANIH U TERAPIJI REUMATOIDNOG ARTRITISA
,
M. Popovic
,
R. Dani
Lj. Stalevic
Abstract
Keywords
References
1.
Vujasinovic N. S u Reumatologija gl.urednik Pilipovic N. 2000;282–322.
2.
Walace J, Mcknightt W, Reuter B, Vergnolle N. NSAID-Induced gastric damage in rats: requirement for inhibition for both ciclooxigenes 1 and 2 Gastroenterology. 2000;(3):706–14.
3.
Vane J. Inhibition of prostaglandine syntesis as a mechanism of action for aspirin -lice drugs. Nat New Biol. 2001;231–2.
4.
Henri D, Lim L, Rodrigues G, L, Gutthans P, Carson S, et al. Variability in risk of gastrointestinal complications wite individual non steroidal anti inflamatory drugs : results of collaborative meta analysis. BMJ. 1996;1563–6.
5.
Shas A, Thjodleifson B, Murray F, Kay E, Barry M, Sigthorsson G, et al. selective inhibition of COX-2 in humans is asociatad with less gastrointestinal injury: a incomparasion of nimulide and naproxen. Gut. 2001;339–46.
6.
Macia M, Carvajal A, Del Pozo J, Vera E, Del Pino A. Hepatotoxicitiy associated with nimesulide:data fro the Spanish Pharmacovigilance System. Clin Pharmacol ther. 2002;596–559.
7.
Jones R. Endolac : Clinical profile of an established selective cyclooxigenase 2 Inhibitor Therapeutic Roles selective COX-2 Inhibitors (Vane JR and Botting RM eds. 2001;482–523.
8.
Martin R, Biswas P, Mann R. The incidence of adverse events and risk factors off upper gastrointestinal disorders associated whit meloxicam use amongst 19,087 patients in general practice in England : cohort study. Br J Clin Pharmacol. 2000;35–42.
9.
Masso G, Patrignani P, Taccomelli S, Rodrigeuz G, L. Variabylity among nestoroidal antiinflamatory drugs in risc of upper gastrointestinal bleding Arthritis Rheum. 2010;1592–601.
10.
Roth S. coming to terms with nonsteroidal anti inflammatory drug gasropaty. Drugs. 2012;873–9.
11.
Bardou M, Barkum A. Preventig the gastrointestinal adverse effects of nesteroidal anti inflamatory drugs: From risk factor identification to risk factor intervention. Joint Bone Spine. 2010;(1):6–12.
12.
Tomasato W, Tsutsumi S, Hoshino T, Hwang H, Mio M. Role of direct cytotoxic effects of NSAIDs in the inductor of gastric lesions. Biochem Pharmacol. 2004;575–83.
13.
Hernandez -Diaz S, Rodrigeuz L. Association between nonsteroidal antiinflammatory drugs and upper gastrointestinal tract bleding/ perforation : an overvi view of epidemiologic studies published in the 1990s. Arch Intern Med. 2000;2093–9.
14.
Schlanskiy B, Joo H, Hwang. Prevention of nesteroidal anti -inflammatory dug induced gastropathy. J gastroenterol. 2009;44–5.
15.
Walace J, Vong L. NSAID-induced gastrointestinal damage and the desing og GI-sprang NSAIDSs. Curr Opin Investig Drugs. 2008;(11):1151–6.
16.
Hawkey C, Kararrach J, Szczepnski L. Omeprazole compared whit misoprostol for ulcers associated with nesteroidal antiinflamatory drugs .Omeprazol vs. Misoprostol for insaed -induced Ulcer Management (OMNIUM) Study Grop. N Engl J Med. 1998;727–34.
17.
Ng Fh W, Sy. Lam Kf i sur. Famotidine is inferior to pantoprazol in preventing recurrence of aspirin -related peptic ulcers or erosions. Gastroentrrology. 2010;(1):82–8.
18.
Fk C, Lanas A, Scheiman J, Mf Ngyen B, Goldstein H, J. Celecoxib versus Omeprazol and Diklofenac in patiens whit osteoarthrosis and rheumathoid arthritis (Condor): a randoised trial Lancet. 2010;(9736):173–9.
19.
Damjanov D. Odnos nesteroidnih antiinflamatornih lekova i ulceroerozivnih lezija gornjih segmenata gasrointestinalnog trakta /disertacija. 2003;
Citation
Copyright
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Article metrics
Google scholar:
See link
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
